$20.6 BillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
$408 MillionTotal revenue in the last quarter.
-$220 MillionNet income is all revenues minus all expenses including taxes and interest in the last quarter.
-$2.27Earnings per share is the amount of net income that is attributed to each single share outstanding.
$0.00 (0.0%)Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
-61.76xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
$6.33 MillionEarnings before interest expenses and taxes in the last quarter.
0The number of full time employees.
Exact Sciences swung to a large fourth quarter loss due in part to its purchase of Base Genomics.The Street, 15 days ago
MADISON, Wis., Feb. 16, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenue of $466.3 million for the fourth quarter ended Dec. 31, 2020 and ...PR Newswire, 16 days ago
Leerink Partners Stick to Their Buy Rating for Exact Sciences Corp.Investing.com, about 1 month ago